The Epoch Times
The Epoch Times
Focus

Oxford Vaccine

UK News
UK News
|
David English

Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study

Dec 10, 2020
|
David English
FacebookXTruthGettrLinkedInTelegramEmail
Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study
Dec 10
|
FacebookXTruthGettrLinkedInTelegramEmail
UK News
UK News
|
Mary Clark

Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK

Dec 02, 2020
|
Mary Clark
FacebookXTruthGettrLinkedInTelegramEmail
Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK
Dec 02
|
FacebookXTruthGettrLinkedInTelegramEmail
UK News
UK News
|
Simon Veazey

Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People

Nov 19, 2020
|
Simon Veazey
FacebookXTruthGettrLinkedInTelegramEmail
Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People
Nov 19
|
FacebookXTruthGettrLinkedInTelegramEmail
UK News
UK News
|
David English

Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study

Dec 10, 2020
|
David English
FacebookXTruthGettrLinkedInTelegramEmail
Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study
Dec 10
|
FacebookXTruthGettrLinkedInTelegramEmail
UK News
UK News
|
Mary Clark

Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK

Dec 02, 2020
|
Mary Clark
FacebookXTruthGettrLinkedInTelegramEmail
Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK
Dec 02
|
FacebookXTruthGettrLinkedInTelegramEmail
UK News
UK News
|
Simon Veazey

Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People

Nov 19, 2020
|
Simon Veazey
FacebookXTruthGettrLinkedInTelegramEmail
Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People
Nov 19
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.